The company was founded in 2013 and publicly launched at Stanford Medicine X 2015, where serial entrepreneur, inventor, and engineer Michael Golway unveiled the BioAssembly platform for the first time.
Today these platforms are used around the globe to produce tissue models for drug discovery, personalized medicine, and regenerative therapeutics. As the world’s leading biofabrication company, Advanced Solutions enables some of the most well-known global healthcare brands such as Merck, Sanofi, Medtronic, and Johnson & Johnson to innovate their science.
Advanced Solutions has customers in 9 countries and is continuing to expand globally throughout the USA, Europe, and Asia. The company has more than 50 employees globally and is growing rapidly.
BioAssemblyBot® (BAB) is an intelligent, robotic biofabrication platform used to build and assemble biological structures. More than a 3D bioprinter, BioAssemblyBot forms and assembles tissue products on complex surfaces – with six-axes of freedom
BioBot Basic® is an entry-level 3D bioprinting system that enables users to print with up to 5 biomaterials for $4,995
Angiomics™ is a vascularization platform involving isolates of adipose-derived microvessels, which contain all vascular types maintained in the native microvessel structure.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.